Complete financial analysis of Surgery Partners, Inc. (SGRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Surgery Partners, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Investeringsforeningen Bankinvest Globale – Aktier A Fund (BAIGLA.CO) Income Statement Analysis – Financial Results
- Covivio (COV.PA) Income Statement Analysis – Financial Results
- Zicix Corporation (ZICX) Income Statement Analysis – Financial Results
- Quest Rare Minerals Ltd. (QRMLF) Income Statement Analysis – Financial Results
- Dynamatic Technologies Limited (DYNAMATECH.BO) Income Statement Analysis – Financial Results
Surgery Partners, Inc. (SGRY)
About Surgery Partners, Inc.
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.74B | 2.54B | 2.23B | 1.86B | 1.83B | 1.77B | 1.34B | 1.15B | 959.89M | 403.29M | 284.60M | 260.22M |
| Cost of Revenue | 2.10B | 1.96B | 1.73B | 1.48B | 1.41B | 1.36B | 1.01B | 821.20M | 669.33M | 254.18M | 169.84M | 159.35M |
| Gross Profit | 647.50M | 574.90M | 491.40M | 379.80M | 423.80M | 410.03M | 327.42M | 324.24M | 290.57M | 149.11M | 114.76M | 100.87M |
| Gross Profit Ratio | 23.60% | 22.64% | 22.08% | 20.42% | 23.14% | 23.15% | 24.41% | 28.31% | 30.27% | 36.97% | 40.32% | 38.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 120.90M | 102.20M | 104.00M | 97.10M | 88.60M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 120.90M | 102.20M | 104.00M | 97.10M | 88.60M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
| Other Expenses | 198.60M | 112.40M | 60.90M | 48.60M | 75.10M | 63.67M | 25.33M | -3.73M | -119.91M | 21.21M | 17.85M | 14.32M |
| Operating Expenses | 319.50M | 214.60M | 164.90M | 145.70M | 163.70M | 157.23M | 156.37M | 123.66M | 111.83M | 52.66M | 44.18M | 39.58M |
| Cost & Expenses | 2.42B | 2.18B | 1.90B | 1.63B | 1.57B | 1.52B | 1.17B | 944.85M | 781.16M | 306.84M | 214.03M | 198.93M |
| Interest Income | 0.00 | 227.00M | 220.90M | 201.80M | 178.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 193.00M | 234.90M | 221.00M | 201.80M | 178.90M | 147.00M | 117.67M | 100.57M | 100.98M | 62.10M | 32.93M | 28.48M |
| Depreciation & Amortization | 118.10M | 149.60M | 137.90M | 134.20M | 116.50M | 67.44M | 51.93M | 39.55M | 34.55M | 15.06M | 11.66M | 11.21M |
| EBITDA | 446.10M | 460.00M | 401.00M | 277.80M | 336.60M | 144.68M | 251.88M | 245.23M | 59.39M | 65.87M | 69.89M | 72.49M |
| EBITDA Ratio | 16.26% | 19.86% | 20.32% | 18.35% | 18.81% | 18.58% | 19.00% | 21.05% | 10.12% | 27.96% | 28.89% | 27.86% |
| Operating Income | 328.00M | 345.20M | 302.20M | 246.60M | 235.90M | 77.84M | 158.23M | 196.48M | 144.75M | 50.81M | 58.23M | 60.45M |
| Operating Income Ratio | 11.96% | 13.59% | 13.58% | 13.26% | 12.88% | 4.39% | 11.80% | 17.15% | 15.08% | 12.60% | 20.46% | 23.23% |
| Total Other Income/Expenses | -193.00M | -234.90M | -221.00M | -201.80M | -181.30M | -147.00M | -75.95M | -104.30M | -220.89M | -62.10M | -32.93M | -29.31M |
| Income Before Tax | 135.00M | 110.30M | 81.20M | -18.80M | 54.60M | -69.17M | 82.29M | 92.18M | -76.14M | -11.29M | 25.30M | 31.97M |
| Income Before Tax Ratio | 4.92% | 4.34% | 3.65% | -1.01% | 2.98% | -3.90% | 6.14% | 8.05% | -7.93% | -2.80% | 8.89% | 12.29% |
| Income Tax Expense | 300.00K | 23.30M | 10.50M | -20.10M | 8.50M | 26.46M | 53.55M | 7.10M | -148.98M | 15.76M | 7.57M | 6.11M |
| Net Income | -11.90M | 87.00M | 70.70M | 1.30M | 46.10M | -205.71M | -52.99M | 9.45M | 1.43M | -65.90M | -9.06M | 1.92M |
| Net Income Ratio | -0.43% | 3.43% | 3.18% | 0.07% | 2.52% | -11.61% | -3.95% | 0.83% | 0.15% | -16.34% | -3.18% | 0.74% |
| EPS | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.09 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
| EPS Diluted | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.08 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
| Weighted Avg Shares Out | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 48.69M | 48.02M | 36.07M | 48.16M | 48.16M | 48.16M |
| Weighted Avg Shares Out (Dil) | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 49.00M | 48.19M | 37.46M | 48.16M | 48.16M | 48.16M |
Surgery Partners (SGRY) Reports Q2 Loss, Misses Revenue Estimates
Surgery Partners (SGRY) delivered earnings and revenue surprises of 0% and 1.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders
These articles are intended to provide readers with equity investment subjects [stocks, ETFs, REITs] which probably may experience rising market prices in next 3-5 months: Near-term expectations only. They are drawn from a 3,000+ equity population updated daily which infers...
Surgery Partners, Inc. Announces Second Quarter 2022 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., June 29, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2022 results before the market opens on Tuesday, August...
Surgery Partners, Inc. to Present at Upcoming Investor Conference
BRENTWOOD, Tenn., June 02, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), is scheduled to meet with investors at the Jefferies Healthcare Conference, including a presentation on Wednesday, June 8, 2022 at 4:30p.m. (Eastern Time)
Surgery Partners, Inc. to Present at Upcoming Investor Conferences
BRENTWOOD, Tenn., May 04, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), is scheduled to meet with investors at the following healthcare conferences:
Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q1 2022 Results - Earnings Call Transcript
Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Kevin Fischbeck...
Surgery Partners, Inc. Announces First Quarter 2022 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., April 07, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2022 results before the market opens on Tuesday, May...
Surgery Partners, Inc.'s (SGRY) CEO Eric Evans on Q4 2021 Results - Earnings Call Transcript
Surgery Partners, Inc.'s (SGRY) CEO Eric Evans on Q4 2021 Results - Earnings Call Transcript
Surgery Partners (SGRY) Misses Q4 Earnings and Revenue Estimates
Surgery Partners (SGRY) delivered earnings and revenue surprises of -11.54% and 2.51%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners (SGRY) Reports Next Week: Wall Street Expects Earnings Growth
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Source: https://incomestatements.info
Category: Stock Reports